rAAV2-VMD2-hMERTK
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rAAV2-VMD2-hMERTK, covering 2021-07-15 to 2021-07-15. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Subretinal Injection of (rAAV2-VMD2-hMERTK) [Phase 1]